pDriver: a novel method for unravelling personalized coding and miRNA cancer drivers
暂无分享,去创建一个
Thin Nguyen | Vu V H Pham | Cameron P Bracken | Gregory J Goodall | Thuc D Le | Lin Liu | Jiuyong Li | T. Le | Lin Liu | C. Bracken | G. Goodall | Jiuyong Li | Thin Nguyen
[1] D. Ciocca,et al. Estrogen Receptors and Cell Proliferation in Breast Cancer , 1997, Trends in Endocrinology & Metabolism.
[2] Liang Han,et al. MiR-326 regulates cell proliferation and migration in lung cancer by targeting phox2a and is regulated by HOTAIR. , 2016, American journal of cancer research.
[3] Xing-Xing He,et al. The emerging role of miR‐375 in cancer , 2014, International journal of cancer.
[4] Benjamin J. Raphael,et al. CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer , 2015, Genome Biology.
[5] Hyunsuk Shim,et al. Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. , 2010, Biochemical pharmacology.
[6] Tao Zeng,et al. A novel network control model for identifying personalized driver genes in cancer , 2019, PLoS Comput. Biol..
[7] Juan M. Vaquerizas,et al. A census of human transcription factors: function, expression and evolution , 2009, Nature Reviews Genetics.
[8] Ming Lu,et al. TransmiR: a transcription factor–microRNA regulation database , 2009, Nucleic Acids Res..
[9] Hsien-Da Huang,et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database , 2015, Nucleic Acids Res..
[10] Benjamin J. Raphael,et al. Hierarchical HotNet: identifying hierarchies of altered subnetworks , 2018, Bioinform..
[11] John Quackenbush,et al. Estimating Sample-Specific Regulatory Networks , 2015, iScience.
[12] Mingming Jia,et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..
[13] D. Bartel,et al. Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.
[14] K. Lukong,et al. Signaling pathways in breast cancer: therapeutic targeting of the microenvironment. , 2014, Cellular signalling.
[15] Sergey Brin,et al. The Anatomy of a Large-Scale Hypertextual Web Search Engine , 1998, Comput. Networks.
[16] A. Vinayagam,et al. A Directed Protein Interaction Network for Investigating Intracellular Signal Transduction , 2011, Science Signaling.
[17] Lei Zhang,et al. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy , 2018, Bioinform..
[18] Wei Zhang,et al. Functional analyses of microRNA-326 in breast cancer development , 2019, Bioscience reports.
[19] Brock C Christensen,et al. MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma , 2009, Clinical Cancer Research.
[20] J. P. Hou,et al. DawnRank: discovering personalized driver genes in cancer , 2014, Genome Medicine.
[21] Andrew D. Rouillard,et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..
[22] C. Sander,et al. Genome-wide analysis of non-coding regulatory mutations in cancer , 2014, Nature Genetics.
[23] B. Liang,et al. A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis , 2017, PloS one.
[24] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[25] Wenjun Liu,et al. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients. , 2018, Cancer biomarkers : section A of Disease markers.
[26] I. Ebersberger,et al. Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype , 2019, Nature Communications.
[27] Kiwon Jang,et al. Predicting the recurrence of noncoding regulatory mutations in cancer , 2016, BMC Bioinformatics.
[28] Guoxin Zhang,et al. MiR‐577 suppresses epithelial‐mesenchymal transition and metastasis of breast cancer by targeting Rab25 , 2018, Thoracic cancer.
[29] Samuel Leung,et al. Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype , 2008, Clinical Cancer Research.
[30] Vu V H Pham,et al. DriverGroup: a novel method for identifying driver gene groups. , 2020, Bioinformatics.
[31] A. Bashashati,et al. DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer , 2012, Genome Biology.
[32] Xiaowei Wang,et al. OncomiR: an online resource for exploring pan-cancer microRNA dysregulation , 2018, Bioinform..
[33] Joshua D. Campbell,et al. NetSig: network-based discovery from cancer genomes , 2017, Nature Methods.
[34] Jian Pei,et al. Continuous Influence Maximization: What Discounts Should We Offer to Social Network Users? , 2016, SIGMOD Conference.
[35] Gary D Bader,et al. Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers , 2013 .
[36] R. Kálmán. Mathematical description of linear dynamical systems , 1963 .
[37] Albert-László Barabási,et al. Controllability of complex networks , 2011, Nature.
[38] Jiuyong Li,et al. Computational methods for cancer driver discovery: A survey , 2020, Theranostics.
[39] C. Sander,et al. Mutual exclusivity analysis identifies oncogenic network modules. , 2012, Genome research.
[40] A. Gonzalez-Perez,et al. Functional impact bias reveals cancer drivers , 2012, Nucleic acids research.
[41] S. Påhlman,et al. Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors , 2012, Upsala journal of medical sciences.
[42] Lei Wang,et al. hsa‐mir‐3199‐2 and hsa‐mir‐1293 as Novel Prognostic Biomarkers of Papillary Renal Cell Carcinoma by COX Ratio Risk Regression Model Screening , 2017, Journal of cellular biochemistry.
[43] H. Dweep,et al. miRWalk2.0: a comprehensive atlas of microRNA-target interactions , 2015, Nature Methods.
[44] Maoguo Gong,et al. Influence maximization in social networks based on discrete particle swarm optimization , 2016, Inf. Sci..
[45] Jiuyong Li,et al. CBNA: A control theory based method for identifying coding and non-coding cancer drivers , 2019, PLoS Comput. Biol..
[46] Z. Ghaemi,et al. MicroRNA-326 Functions as a Tumor Suppressor in Breast Cancer by Targeting ErbB/PI3K Signaling Pathway , 2019, Front. Oncol..
[47] A. Valencia,et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia , 2015, Nature.
[48] X. Hua,et al. DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies , 2019, Nucleic acids research.
[49] Finn Drabløs,et al. Update of the FANTOM web resource: high resolution transcriptome of diverse cell types in mammals , 2016, Nucleic Acids Res..
[50] Athanasios Fevgas,et al. DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions , 2014, Nucleic Acids Res..
[51] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .
[52] N. Kosaka,et al. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A , 2018, Proceedings of the National Academy of Sciences.
[53] David Tamborero,et al. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes , 2013, Bioinform..
[54] Xl Li,et al. miR-760 mediates chemoresistance through inhibition of epithelial mesenchymal transition in breast cancer cells. , 2016, European review for medical and pharmacological sciences.